Home » WEX PHARMACEUTICALS IN DISPUTE WITH ASIAN INVESTOR OVER PATENT, DEBENTURES
WEX PHARMACEUTICALS IN DISPUTE WITH ASIAN INVESTOR OVER PATENT, DEBENTURES
WEX Pharmaceuticals Inc., whose stock was halted Tuesday on the Toronto market, says it's in a dispute with an Asian investor over debentures and a drug patent. The Vancouver-based firm (TSX:WXI) said Wednesday it's in discussions about unsecured convertible debentures worth $5.1 million US that were issued in June 2004 by subsidiary Wex Medical Ltd. to three investment funds managed by a major Asian financial institution.
Canada.com (http://www.canada.com/businesscentre/story.html?id=d60c01e4-bf80-4281-a0a3-3d3f4ca5f4b9)
KEYWORDS FDAnews Drug Daily Bulletin
Upcoming Events
-
25Apr
-
07May
-
14May
-
30May